Modality of chronic renal replacement therapy and survival-a complete cohort from Finland, 2000-2009

被引:12
作者
Haapio, Mikko [1 ]
Helve, Jaakko [2 ]
Kyllonen, Lauri [3 ,4 ]
Gronhagen-Riska, Carola [2 ,5 ]
Finne, Patrik [1 ,5 ]
机构
[1] Univ Helsinki, Cent Hosp, Div Nephrol, Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland
[3] Finnish Kidney Transplant Registry, Dept Surg, Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Helsinki, Finland
[5] Finnish Registry Kidney Dis, Helsinki, Finland
关键词
dialysis modality; haemodialysis; peritoneal dialysis; renal replacement therapy; survival; AMBULATORY PERITONEAL-DIALYSIS; ADJUSTED MORTALITY-RATES; CONGESTIVE-HEART-FAILURE; PATIENT SURVIVAL; SIMILAR OUTCOMES; ESRD PATIENTS; HEMODIALYSIS; DISEASE; EUROPE; RISK;
D O I
10.1093/ndt/gft326
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Studies on dialysis modality and survival have shown conflicting results, mostly due to insufficient and varying control of confounding factors. Using comprehensive data on a well-defined patient cohort, we therefore investigated the association of dialysis modality with survival on chronic renal replacement therapy (RRT) and whether this association varies between subgroups of patients. Survival analyses included all adult patients entering chronic RRT in Finland between 2000 and 2009 and used information obtained from the Finnish Registry for Kidney Diseases and the Finnish Kidney Transplant Registry. In our primary intention-to-treat (ITT) analysis, we calculated relative risk of death according to dialysis modality on Day 91 from RRT start, comparing peritoneal dialysis (PD) to haemodialysis (HD). Relative risks were adjusted for putative confounders. Interactions between treatment groups and other variables were estimated. Of the total 4463 patients, 42 died during the 10 years of follow-up. Median survival time was 5.2 years. In unadjusted ITT analysis, relative risk of death of PD patients was 0.65 (95 CI 0.580.73, P 0.001) compared with HD patients. With adjustment for 26 variables, the corresponding relative risk of death was 1.07 (95 CI 0.941.22, P 0.33). When censoring at time of kidney transplantation, the result was similar with a relative risk of death of 1.09 (95 CI 0.951.25, P 0.24) on PD compared with HD. PD is associated with several factors generally related to good prognosis. After comprehensive adjustment for putative confounding factors with the ITT analysis approach, we found no significant difference in survival between PD and HD patients.
引用
收藏
页码:3072 / 3081
页数:10
相关论文
共 50 条
  • [1] Effect of change in renal replacement therapy modality on laboratory variables: a cohort study from the UK Renal Registry
    Rao, Raman
    Ansell, David
    Gilg, Julie A.
    Davies, Simon J.
    Lamb, Edmund J.
    Tomson, Charlie R. V.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (09) : 2877 - 2882
  • [2] Modality transition on renal replacement therapy and quality of life of patients: a 10-year follow-up cohort study
    Sampaio de Brito, Daniela Cristina
    Machado, Elaine Leandro
    Reis, Ilka Afonso
    Moreira, Daniela Pena
    Mascarenhas Nebias, Thiago Henrique
    Cherchiglia, Mariangela Leal
    QUALITY OF LIFE RESEARCH, 2019, 28 (06) : 1485 - 1495
  • [3] Mesothelioma in Finland: 10 Year Population-Based Cohort Between 2000-2009
    Ilonen, Ilkka
    Laaksonen, Sanna
    Salo, Jarmo A.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S349 - S350
  • [4] Survival prognosis after the start of a renal replacement therapy in the Netherlands: a retrospective cohort study
    Hemke, Aline C.
    Heemskerk, Martin B. A.
    van Diepen, Merel
    Weimar, Willem
    Dekker, Friedo W.
    Hoitsma, Andries J.
    BMC NEPHROLOGY, 2013, 14
  • [5] Improved survival of type 2 diabetic patients on renal replacement therapy in Finland
    Kervinen, Marjo
    Lehto, Seppo
    Ikaheimo, Risto
    Karhapaa, Pauli
    Gronhagen-Riska, Carola
    Finne, Patrik
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (03) : 892 - 896
  • [6] Decreasing trends in incidence and prevalence of renal replacement therapy in Croatia from 2000 to 2009
    Cala, Svjetlana
    CLINICAL KIDNEY JOURNAL, 2012, 5 (04): : 309 - 314
  • [7] Survival in children requiring chronic renal replacement therapy
    Chesnaye, Nicholas C.
    van Stralen, Karlijn J.
    Bonthuis, Marjolein
    Harambat, Jerome
    Groothoff, Jaap W.
    Jager, Kitty J.
    PEDIATRIC NEPHROLOGY, 2018, 33 (04) : 585 - 594
  • [8] Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival-A Nationwide Cohort Study from Finland
    Santala, Eerik E. E.
    Murto, Mika O.
    Artama, Miia
    Pukkala, Eero
    Visvanathan, Kala
    Murtola, Teemu J.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (11) : 2376 - 2382
  • [9] Survival prognosis after the start of a renal replacement therapy in the Netherlands: a retrospective cohort study
    Aline C Hemke
    Martin BA Heemskerk
    Merel van Diepen
    Willem Weimar
    Friedo W Dekker
    Andries J Hoitsma
    BMC Nephrology, 14
  • [10] Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009
    Hu, Yi
    Zhao, Qi
    Rao, Jianyu
    Deng, Haiju
    Yuan, Hong
    Xu, Biao
    BMC PUBLIC HEALTH, 2014, 14